-

Veriheal Is Now Offering $10,000 in Scholarships to Further Cannabis Innovation

DENVER--(BUSINESS WIRE)--Many are eager to learn about cannabis. But the rate of available information is not keeping up with the public’s surging demand. As time presses on, more programs committed to learning about cannabis are becoming available. These classes explore concentrations such as pharmacology, botany, and business where those interested are able to specialize. The struggle that still remains is that information is still very limited and the country is in dire need of it.

Veriheal, a cannatech company, aims to mitigate this predicament. The core mission of Veriheal is to help those interested in becoming medical cannabis patients and be their go-to cannabis resource. Depending on state laws, there can be several hoops to jump through. Even worse, there is very little assistance to help navigate the process. Veriheal streamlines this process by connecting prospective patients to doctors who can certify qualifying conditions, a requirement for all medical cannabis programs.

To further cannabis innovation, Veriheal is now offering a scholarship for students that show an interest in the cannabis industry. The company places the utmost value on quality education and wants to help students in need by offering financial aid to those currently enrolled in a university in the US. This scholarship is not limited to any specific concentration, however, selections will be based on the best combination of “sustainability, community, awareness, and innovation for the future of cannabis not only as an industry but as a medical medium.” To apply, students will submit the required information as requested on the scholarship website. The deadline is July 30, 2020.

Higher education is certainly an investment in the future. Veriheal is willing to take stock in motivated students who want to innovate and contribute extensively to the cannabis sector. In a budding industry that is constantly experiencing new developments, it’s crucial to have circulation of intrigue, and fresh minds that are devoted to strengthening progress. Veriheal recognizes this importance and is inspired to lend a helping hand wherever possible to promote worldwide accessibility to medical cannabis.

Contacts

Media Contact Information:
Anthony Dutcher
833-663-7284
https://www.veriheal.com/contact-us/ and select the Press/Media option

More News From Veriheal

Veriheal Expands Patient Support Services With State-Compliant Medical Cannabis Letters

DENVER--(BUSINESS WIRE)--Veriheal, a leading health-tech company specializing in personalized cannabis access, announced this month the expansion of its services to include support beyond certification. The new offerings include state-compliant, physician-signed letters that provide documentation of lawful cannabis use by medical marijuana patients. Veriheal’s expanded suite includes medical cannabis letters of necessity and medical diagnosis summaries that confirm lawful marijuana use. These d...

Call for Papers: Veriheal Invites Submissions for Cannabis Research and Education

DENVER--(BUSINESS WIRE)--Veriheal is now accepting submissions for its “Cannabis Education and Research Collection.”. This collection seeks to close the gap between cutting-edge research and public knowledge of the plant’s vast potential by highlighting the perspectives and expertise of the next generation of cannabis professionals. For this collection, the company welcomes research on a range of themes, including but not restricted to: - Discoveries around cannabinoid pharmacology and the medi...

Veriheal’s 2023 Cannabis Industry Report: Analyzing Market Stats and Consumer Trends

DENVER--(BUSINESS WIRE)--Veriheal, health-tech industry frontrunner, released its latest cannabis statistics report which includes consumer insights and industry projections for the next five years. The 2023 report is the first to analyze surveys completed dating back to the company’s inception in 2017. The result paints a comprehensive picture of the health goals and preferences of a staggering 1.75 million U.S. medical cannabis patients. Projections from the 2023 report illustrate the scale o...
Back to Newsroom